Business opportunity

​People worldwide are living longer and advanced age is a major risk factor for many blinding eye diseases. The frequency of visual impairment associated with ocular diseases of aging is increasing rapidly and experts predict that by 2030, rates of vision loss will double along with the aging population.  Many blinding eye diseases can not be treated with existing drug therapy and there is a huge unmet medical need. 
​
With a global sale of nearly USD 27 Billion in 2017 and an expected growth at a CARG of 6% the next decade, ophthalmic drugs form one of the most interesting markets in the pharmaceutical industry.